Figure 3

The survival and disease control outcomes of T1/T2 and T3/T4 human papillomavirus (HPV)− and T1/T2 and T3/T4 HPV+ oropharyngeal squamous cell carcinoma (OPSCC) in our series: (a) disease-free survival curves; (b) overall survival curves; (c) local recurrence rates; (d) regional neck recurrence rates; (e) distant metastases rates; (f) second primary malignancies rates.